×

GW Pharma CEO: Our most important clinical event

3:47 PM ET Mon, 14 March 2016

GW Pharmaceuticals' CEO Justin Gover says this successful clinical trial for new drug Epidiolex is not only good for the company but also for cannabinoids in modern medicine. CNBC's Meg Tirrell reports.